Remibrutinib oral treatment clinical trials

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

This study looks at a new medicine called remibrutinib for people with relapsing multiple sclerosis (RMS). It compares switching from their current medicine, ocrelizumab, to remibrutinib, versus staying on ocrelizumab, to see if it's safe and works well.